Biology Reference
In-Depth Information
59. Parr CE, Sullivan DM, Paradiso AM, Lazarowski ER, Burch LH, Olsen JC, Erb L, Weisman
GA, Boucher RC, Turner JT. (1994) Cloning and expression of a human P
2U
nucleotide
receptor, a target for cystic fibrosis pharmacotherapy. Proc Natl Acad Sci USA 91:3275-9.
60. Pearson JD, Gordon JL. (1979) Vascular endothelial and smooth muscle cells in culture
selectively release adenine nucleotides. Nature 281:384-6.
61. Pedersen S, Pedersen SF, Nilius B, Lambert IH, Hoffmann EK. (1999) Mechanical stress
induces release of ATP from Ehrlich ascites tumor cells. Biochim Biophys Acta 1416:271-84.
62. Pillois X, Chaulet H, Belloc I, Dupuch F, Desgranges C, Gadeau AP. (2002) Nucleotide
receptors involved in UTP-induced rat arterial smooth muscle cell migration. Circ Res
90:678-81.
63. Ralevic V, Burnstock G. (1991) Roles of P2-purinoceptors in the cardiovascular system.
Circulation 84:1-14.
64. Renault MA, Jalvy S, Belloc I, Pasquet S, Sena S, Olive M, Desgranges C, Gadeau AP. (2003)
AP-1 is involved in UTP-induced osteopontin expression in arterial smooth muscle cells. Circ
Res 93:674-81.
65. Renault MA, Jalvy S, Potier M, Belloc I, Genot E, Dekker LV, Desgranges C, Gadeau AP.
(2005) UTP induces osteopontin expression through a coordinate action of NFkappaB, acti-
vator protein-1, and upstream stimulatory factor in arterial smooth muscle cells. J Biol Chem
280:2708-13.
66. Robson SC, Kaczmarek E, Siegel JB, Candinas D, Koziak K, Millan M, Hancock WW, Bach
FH. (1997) Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp
Med 185:153-63.
67. Ross R. (1995) Cell biology of atherosclerosis. Annu Rev Physiol 57:791-804.
68. Rumjahn SM, Javed MA, Wong N, Law WE, Buxton IL. (2007) Purinergic regulation of
angiogenesis by human breast carcinoma-secreted nucleoside diphosphate kinase. Br J Cancer
97:1372-80.
69. Satterwhite CM, Farrelly AM, Bradley ME. (1999) Chemotactic, mitogenic, and angiogenic
actions of UTP on vascular endothelial cells. Am J Physiol 276:H1091-7.
70. Sauzeau V, Le Jeune H, Cario-Toumaniantz C, Vaillant N, Gadeau AP, Desgranges C, Scalbert
E, Chardin P, Pacaud P, Loirand G. (2000) P2Y
1
,P2Y
2
,P2Y
4
,andP2Y
6
receptors are coupled
to Rho and Rho kinase activation in vascular myocytes. Am J Physiol Heart Circ Physiol
278:H1751-61.
71. Senger DR, Perruzzi CA, Papadopoulos A. (1989) Elevated expression of secreted phospho-
protein I (osteopontin, 2ar) as a consequence of neoplastic transformation. Anticancer Res
9:1291-9.
72. Seye CI, Gadeau AP, Daret D, Dupuch F, Alzieu P, Capron L, Desgranges C. (1997)
Overexpression of P2Y
2
purinoceptor in intimal lesions of the rat aorta. Arterioscler Thromb
Vasc Biol 17:3602-10.
73. Seye CI, Kong Q, Erb L, Garrad RC, Krugh B, Wang M, Turner JT, Sturek M, Gonzalez FA,
Weisman GA. (2002) Functional P2Y
2
nucleotide receptors mediate uridine 5
-triphosphate-
induced intimal hyperplasia in collared rabbit carotid arteries. Circulation 106:2720-6.
74. Seye CI, Yu N, Gonzalez FA, Erb L, Weisman GA. (2004) The P2Y
2
nucleotide recep-
tor mediates vascular cell adhesion molecule-1 expression through interaction with VEGF
receptor-2 (KDR/Flk-1). J Biol Chem 279:35679-86.
75. Seye CI, Yu N, Jain R, Kong Q, Minor T, Newton J, Erb L, Gonzalez FA, Weisman GA.
(2003) The P2Y
2
nucleotide receptor mediates UTP-induced vascular cell adhesion molecule-
1 expression in coronary artery endothelial cells. J Biol Chem 278:24960-5.
76. Shen BQ, Lee DY, Zioncheck TF. (1999) Vascular endothelial growth factor governs endothe-
lial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C
signaling pathway. J Biol Chem 274:33057-63.
77. Shen J, Seye CI, Wang M, Weisman GA, Wilden PA, Sturek M. (2004) Cloning, up-regulation,
and mitogenic role of porcine P2Y
2
receptor in coronary artery smooth muscle cells. Mol
Pharmacol 66:1265-74.
Search WWH ::
Custom Search